Wall Street is going crazy as to which company will be the jewel of all jewels when it comes to these vaccines. It only shows how completely foolish investment agencies and banks are when it comes to understanding governance. They aren't capable of governance, but, only greed.
The fact of the matter is every company that produces a viable vaccine will be important. There is no one particular company that has the inside track. I held Moderna as a special case because it is, that doesn't mean other companies aren't going to have very viable solutions as well. Moderna is a breakthrough company and it's future, like it's past, is going to be highly important to the wellness of people. I am more than thrilled this company has succeeded.
This is a time when every company has put forward it's best effort. They are all needed. We have seen some vaccines with adverse results, that doesn't mean a very good vaccine will not be discovered and effective.
I would encourage every company currently involved in vaccine discovery to continue on this path into their future. They have embarked on a principle that protects human life and they do not know exactly where their scientists will take them. I would expect every viable vaccine to be marketed successfully and distributed with great success to people. There are nearly eight billion people in the world today. That is a lot of vaccine and we MUST ELIMINATE this virus from the face of Earth. Don't stop now!
November 16, 2020
By Denise Grady
Moderna (click here) is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.
The drugmaker Moderna announced on Monday that its coronavirus vaccine was 94.5 percent effective, based on an early look at the results from its large, continuing study.
Researchers said the results were better than they had dared to imagine. But the vaccine will not be widely available for months, probably not until spring.
Moderna is the second company to report preliminary data on an apparently successful vaccine, offering hope in a surging pandemic that has infected more than 53 million people worldwide and killed more than 1.2 million. Pfizer, in collaboration with BioNTech, was the first, reporting one week ago that its vaccine was more than 90 percent effective.
The need is urgent. U.S. cases are soaring, setting new records every day. There have been more than 11 million cases and 246,000 deaths. The disease is killing more than 1,100 Americans a day, and the last million cases occurred in just six days. Some states and cities are reinstating lockdowns, restricting gatherings and closing schools once again....
Moderna (click here) is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.
The drugmaker Moderna announced on Monday that its coronavirus vaccine was 94.5 percent effective, based on an early look at the results from its large, continuing study.
Researchers said the results were better than they had dared to imagine. But the vaccine will not be widely available for months, probably not until spring.
Moderna is the second company to report preliminary data on an apparently successful vaccine, offering hope in a surging pandemic that has infected more than 53 million people worldwide and killed more than 1.2 million. Pfizer, in collaboration with BioNTech, was the first, reporting one week ago that its vaccine was more than 90 percent effective.
The need is urgent. U.S. cases are soaring, setting new records every day. There have been more than 11 million cases and 246,000 deaths. The disease is killing more than 1,100 Americans a day, and the last million cases occurred in just six days. Some states and cities are reinstating lockdowns, restricting gatherings and closing schools once again....
